Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Raymond Clutts who wrote (886)	3/4/1999 2:10:00 PM
From: RCMac	Read Replies (1) \| Respond to of 3202

Raymond, There is some discussion of the article over on the T/FIF Portfolio thread, starting at reply 656. Here is Rick Harmon's post:: Message 8145020 My sense is that the slow-moving pharmas are too late to the game, but I'll leave it to the better-qualified to comment in detail. Presumably Rocketman will chime in here with a contemptuous guffaw about the article, various passionate denunciations, and a forcefully-articulated description of why INCY's patent position will trump big pharma's too-late efforts. --RCM